Your session is about to expire
← Back to Search
Behavioural Intervention
At-home tDCS for Autism
Phase 2
Recruiting
Research Sponsored by Holland Bloorview Kids Rehabilitation Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Children with a diagnosis of autism spectrum disorder and self-regulation impairment or social communication challenges
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0 weeks, 6 weeks, 18 weeks
Summary
This trial explores if a safe, non-invasive brain stimulation can help improve social communication and self-regulation in youth with Autism Spectrum Disorder.
Who is the study for?
This trial is for children with Autism Spectrum Disorder (ASD) who have difficulties with self-regulation or social communication. They must be able to participate in at-home brain stimulation treatments.
What is being tested?
The study tests if a home-based brain stimulation technique, called tDCS, can help improve social communication and behavior in kids with ASD. Participants are randomly assigned to either the real tDCS or a sham (fake) treatment for three weeks.
What are the potential side effects?
tDCS is generally safe and tolerable. Possible side effects may include mild discomfort at the site of stimulation, itching, tingling during the application, headache, fatigue, and nausea.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My child has autism with difficulties in self-regulation or social communication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0 weeks, 6 weeks, 18 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0 weeks, 6 weeks, 18 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adherence
Attrition
Blinding
+1 moreSecondary study objectives
Inhibitory control
Magnetic Resonance Imaging (MRI)
Overall Clinical Change
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: tDCSExperimental Treatment1 Intervention
active tDCS
Group II: ShamPlacebo Group1 Intervention
sham tDCS
Find a Location
Who is running the clinical trial?
Holland Bloorview Kids Rehabilitation HospitalLead Sponsor
67 Previous Clinical Trials
14,047 Total Patients Enrolled
23 Trials studying Autism Spectrum Disorder
8,841 Patients Enrolled for Autism Spectrum Disorder
Share this study with friends
Copy Link
Messenger